WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Nov 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-11-18

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-18	Common Stock	S	10000.0000	$51.7237	Disposed	811895.6717	Direct
2014-11-19	Common Stock	S	5918.0000	$50.8436	Disposed	805977.6717	Direct
2014-11-20	Common Stock	S	4082.0000	$50.9143	Disposed	801895.6717	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2705.6000	Indirect
Common Stock	24526.1800	Indirect

Footnotes

F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $51.65 to $51.81, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

F2: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $50.75 to $51.08, inclusive.

F3: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $50.83 to $50.95, inclusive.